IMS Health, a US-based provider of information, services and technology for the healthcare industry, has announced the launch of IMS SiteOptimizer. The product is a cloud-based solution that seeks to help clinical trial organisations more effectively identify and assess trial site locations and recruit best-performing investigators.
Leveraging the company’s DecisionView technology platform, the new offering is designed to capture and analyse enrollment performance for clinical trial investigative sites and investigators. With this insight, study teams can reportedly build optimised site rosters based on real-world performance, identifying sites and selecting investigators based on their experience with an indication, geographic location and available capacity.
IMS SiteOptimizer is available through the company’s Clinical Trial Performance Optimization unit, part of IMS’ Healthcare Value Solutions business. IMS Healthcare Value Solutions seeks to connect healthcare stakeholders through real-world evidence to demonstrate the value of medicines, enhance quality and drive improved results.
